Cardiorespiratory Fitness Tied to Reduced Cancer Incidence, Mortality in Men
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 3, 2023 -- Higher levels of cardiorespiratory fitness (CRF) are associated with a reduced risk for incidence and mortality from specific cancers among men, according to a study published online June 29 in JAMA Network Open.
Elin Ekblom-Bak, Ph.D., from The Swedish School of Sport and Health Sciences in Stockholm, and colleagues conducted a prospective cohort study in a population of men who completed a health profile assessment between October 1982 and December 2019 in Sweden to examine the association between CRF and prostate, colon, and lung cancer incidence and mortality. Data were analyzed for 177,709 men.
The researchers found that higher levels of CRF were associated with a significantly lower risk for colon and lung cancer incidence (hazard ratio, 0.98 for both) and with an increased risk for prostate cancer incidence (hazard ratio, 1.01). A lower risk for death due to colon, lung, and prostate cancer was seen in association with higher CRF (hazard ratios, 0.98, 0.97, and 0.95, respectively). For colon cancer incidence, the associations remained for moderate and high levels compared with very low levels of CRF (hazard ratios, 0.72 and 0.63, respectively) in fully adjusted models. For prostate cancer mortality, the associations remained for low, moderate, and high CRF (hazard ratios, 0.67, 0.57, and 0.29, respectively). Only high CRF was significant for lung cancer mortality (hazard ratio, 0.41).
"If these findings can be supported with randomized clinical trials, CRF appears to have a potentially important role in reducing the risk of developing and dying from certain common cancers in men," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.